UK’s New Clinical Trial Law Takes Effect: Faster Review for Low-Risk Studies, Alongside Higher Transparency Obligations
The most extensive reform of clinical trial regulations in more than two decades creates fast-track pathways for low-risk research and certain amendments; the other side of the bargain is that public registration, results disclosure, and communication with participants are shifting from advocacy to legal obligations.